Brief: Allarity Therapeutics To Be Granted European Patent For Drp Companion Diagnostic For Stenoparib
22/10/2024 13:42
Oct 22 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS TO BE GRANTED EUROPEAN PATENT FOR
DRP®
COMPANION DIAGNOSTIC FOR STENOPARIB
* ALLARITY THERAPEUTICS INC: PATENT APPLICATIONS FOR
STENOPARIB
DRP(®) ARE ALSO PENDING IN US, JAPAN, CHINA, AUSTRALIA, AND
INDIA
Source text for Eikon: ID:nGNX8wpb8Y
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic